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Abstract 
 
Overexpression of S100P promotes breast cancer metastasis in animals and elevated levels in primary 
breast cancers are associated with poor patient outcomes. S100P can differentially interact with 
nonmuscle myosin (NM) isoforms (IIA>IIC>IIB) leading to redistribution of actomyosin filaments to 
enhance cell migration. Using NMIIA-depleted COS-7 cells, S100P is now shown to interact directly 
with αβ-tubulin in vitro and in vivo with an equilibrium Kd of 2-3x10-7M. The overexpressed S100P 
is located mainly in nuclei and microtubule organizing centres (MTOC) and it significantly reduces 
their number, slows down tubulin polymerisation and enhances cell migration in S100P-induced 
COS-7 or HeLa cells. It fails, however, to significantly reduce cell adhesion, in contrast to NMIIA- 
containing S100P-inducible HeLa cells. When taxol is used to stabilize MTs or colchicine to dissociate 
MTs, S100P’s stimulation of migration is abolished. Affinity-chromatography of tryptic digests of α 
and β-tubulin on S100P-bound beads identifies multiple S100P-binding sites consistent with S100P 
binding to all 4 half molecules in gel-overlay assays. When screened by NMR and ITC for interacting 
with S100P, four chemically-synthesised peptides show interactions with low micromolar 
dissociation constants. The two highest affinity peptides significantly inhibit binding of S100P to α,β-
tubulin and, when tagged for cellular entry, also inhibit S100P-induced reduction in tubulin 
polymerisation and S100P-enhancement of COS-7 or HeLa cell migration. A third peptide incapable 
of interacting with S100P also fails in this respect. Thus S100P can interact directly with two 
different cytoskeletal filaments to independently enhance cell migration, the most important step in the 
metastatic cascade. 
 
Introduction 
 
The major cause of death from the commonly occurring cancers is due to metastasis, the process of 
tumour dissemination from its primary site to distant organs [1]. This dissemination process is the 
major obstacle to successful treatment of breast and other commonly-occurring cancers, since the 
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primary tumour can be surgically excised successfully, but disseminated disease is much more 
difficult to treat [2]. Metastasis occurs in multiple steps, the first and perhaps the most important step is 
the cancer cells’ ability to migrate away from the primary tumour [3]. Although multiple steps are 
required for the metastatic process, certain gene products, called metastasis-inducing proteins [4] can 
induce metastasis when expressed in rodents [5], providing they can act on a cell which is already 
neoplastic [6]. One such group includes some members of the S100 family of small, calcium-binding 
regulatory proteins [5]; one of the best studied is S100P [7, 8]. Our previous work demonstrated that 
S100P promotes cell migration and induces metastasis in an animal model of breast cancer, and that 
elevated levels of S100P in primary human breast cancer are associated with shorter patient survival 
times [9]. More recently, we found that S100P differentially interacts with nonmuscle myosin (NM) 
isoforms in vitro and in vivo, binding preferentially to NMIIA rather than to NMIIB or IIC. This 
differential interaction causes the redistribution of the microfilaments and focal adhesion sites and 
thereby facilitates, in part, increases in migration of the S100P-overexpressing cells [10]. This work, 
together with that on S100A4 [11, 12] demonstrates that the effect of both these S100 proteins on the 
actomyosin cytoskeleton is important in cancer cell migration in vitro and on metastasis in vivo. This 
interaction between the cytoskeleton and cell motility can also occur in noncancerous cells such as 
trophoblasts [13]. 
The cytoskeleton, however, is composed of three types of filaments, microfilaments containing 
nonmuscle actin and myosin, microtubules (MTs) containing α, β-tubulins, and intermediate filaments 
containing cytokeratins/vimentin. The first two types of filaments are both important in cell migration 
[14]. Nonmuscle actomyosin filaments are the major machinery of cell adhesion, polarity and 
migration, whilst MTs are active components of the motile machinery of the reticulopodia [15], 
flagella and the tails of sperm [16]. However, in contrast to the actomyosin filaments, there are few 
definitive experiments to show that MTs are actively involved in cancer cell migration. Stabilization of 
MT by chemicals, such as taxol, normally inhibits cell migration [17, 18], whilst the effects of MT- 
disrupting reagents, such as colchicine and nocodazole, are dependent on the cell type [19, 20]. The 
cellular response to such MT-disrupting agents in the short term is to increase cell migration in some 
cells, but to decrease it in others [21]. Theoretically, the MTs radiating from the MT organising 
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centres (MTOCs) to the cellular peripheries provide strong resistance to changes in cell shape and to 
migration, unless the MTs are dynamically regulated or released from the MTOCs [22]. 
The individual S100 proteins have been reported to interact inter alia with either nonmuscle myosin or 
with tubulin, although with different binding affinities [23]. For example, S100A1 and S100B can 
interact with tubulin in a calcium-dependent manner [24] and disrupt the assembly of MT [25]. 
Decreasing S100A1 is able to increase tubulin levels and this change alters neurite organisation in P12 
cells [26]. In contrast, the S100A9/A8 (MRP14/MRP8) complex promotes tubulin polymerisation in 
vivo and is an essential component in the MAP-kinase-p38-induced migration of macrophages [27]. 
However, it is not known whether any member such as S100P can bind directly to tubulin as well as to 
NMIIA, and thereby also influence cell migration. To test this hypothesis we have established 
S100P-inducible cell lines from COS-7 cells which have been reported to contain no NMIIA [28] and 
studied the effects of S100P on cell migration and the possible involvement of the microtubular 
machinery in this NMIIA-deficient as well as in an NMIIA-intact cell system
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Materials and Methods 
Cell lines and cell migration assay 
Rama 37 and S100P-inducible Rama 37, HeLa and S100P-inducible HeLa cells were produced and 
cultured as described previously [28]. The COS-7 monkey kidney cell line was obtained from ATCC 
cell bank and was reported to contain no nonmuscle myosin IIA [28]. S100P-inducible COS-7 cells 
were generated as before for HeLa cells [10] with 2 plasmids: pBTE to express the doxycycline 
regulatory element rHTA2(s)-m2 and pTRE-ins to express the target protein [29]. Three inducible 
clones derived from the COS-7 cells were termed COS-7 S7, S10 and S23. The concentration of 
doxycycline and the incubation period were optimized at 1µg/ml and 24h for all the inductions and 
the level remained constant for at least a further 48h. All cell lines are clonal in origin and hence have the 
same genetic background. They are used within 5 passages or about 15 generations to reduce variability 
due to spontaneous transformations. 
Cell migration assays were performed using Boyden chamber transwells separated by a membrane 
with 8µm diameter pores, as described previously [10]. Usually the cells were plated in Transwells 
and separately in 24 well plates without or with 1µg/ml doxycycline and experiments terminated after 
24h incubation. The upper side of the membrane in the transwells was wiped clean, the lower side 
stained with Quick-Diff Kit (Polysciences, Germany) and the number of migrating cells counted (M). 
The total numbers of cells in the wells for growth control (G) were also counted using a cell counter. 
Cell migration rate (%)=M/G x 100. In order to standardise results between different experiments, the 
cell line controls were usually set to 100% migration and changes relative to their value were shown 
for most results. To test the effects of tubulin peptides on S100P-enhanced cell migration, 20µM 
peptides tagged for cell entry were added 8h after doxycycline induction of S100P-inducible COS-7 
cells in the Transwells, remaining procedures were the same as above. There was no discernable 
reduction in cell numbers on the membranes of parallel wells to those measuring transmembrane 
migration due to possible toxicity of tagged peptides, nor increase due to overexpression of S100P in 
agreement with a previous report (10). 
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Cell adhesion assays 
For kinetics of attachment either HeLa A3 or COS-7 S10 cells were induced with 1µg/ml doxycycline 
48h prior to experiment and 2x105 uninduced or induced cells in 1ml were added to 24 well tissue 
culture dishes and allowed to adhere at 37oC. At the given time (30min to 2h) cells were washed x2 with 
PBS and detached with 250µl 0.05% (v/v) trypsin in versene for 5min at 37oC, neutralized in serum-
containing media (SCM) (10), counted and the percent of seeded cells recorded. For strength of 
adhesion the same cells were seeded in 24 well tissue culture dishes so as to yield 80% confluence in 
24h. In all cases identical dishes were set up for test and control. After 24h, wells were washed x2 and 
detached with 250µl, 0.0125% (v/v) trypsin in versene for 5 min at 37oC. Wells were then carefully 
washed x2 to remove weak binders. Trypsin in versene (250 µl of 0.05% (v/v)) was then added to both 
test dish and control dish for 5 min to remove all cells from the well, neutralized with SCM and counted. 
The proportion of cells remaining after the weak digestion step was determined from the ratio of results 
from test and control plates.  All assays were performed in triplicate. 
 
Production of tubulin / fragments  
The coding sequences for full length (human) α-tubulin and for N-terminal and C-terminal halves of α 
or β-tubulin were generated using PCR with specific primers shown in Supplementary Table S1 and 
sub-cloned into pET16(b) for expressing and purifying His-tagged full length α-tubulin and His-tagged 
tubulin fragments in E.coli, as described previously [10]. Beta-tubulin was purchased from Abcam. 
 
Gel Overlay Assay 
Equal molar proteins (1 μM) were subjected to SDS PAGE on 10% (w/v) polyacrylamide gels. One gel 
was stained with Coomassie Blue to check equal loading and the other electroblotted onto PVDF 
membrane. Three µg/ml S100P in Gel Overlay Buffer were added to the membrane and the contents 
incubated at 4°C overnight. After extensive washing, the presence of bound S100P was probed with 
mouse anti-S100P as described for Western Blotting.  
 
Western Blotting  
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Tween µg cell lysates were subjected to SDS-PAGE and electrically blotted on to PVDF membrane. 
After blocking with 2% BSA, the blot was probed with rabbit anti-ß-tubulin (Abcam), rabbit anti-actin 
(Abcam), rabbit anti-NMIIA (Abcam) or rabbit anti-S100P (R&D system). After extensive washing, 
anti-rabbit-HRP (Santa Cruz) 1/10,000 was used and the bands were visualized using ECL and their 
densities were measured using Image Lab software.    
 
Binding studies 
For Western blotting, S100P was detected using mouse anti-S100P monoclonal antibody (mAb) (1:50 
dilution) (BD Biosciences) which showed no cross-reaction with S100A1, A2 or A4 proteins [9]. 
Anti-tubulin (α, β), anti-actin from Sigma and anti-nonmuscle myosin IIA (NMIIA) from Covance 
(Princetown, NJ) were used as described previously [9, 10]. α-tubulin was synthesised by recombinant 
means (Supplementary Materials and Methods) (Table S1) and β-tubulin purchased from Creative 
BioMart (Shirley, USA). 
For pulldown assays, S100P-inducible COS-7 cells were incubated with doxycycline for 16h and 
lysed in 20mM Tris-HCl pH 8.0, 150mM NaCl and 1% (v/v) Nonidet P-40 (NP-40) with 0.5mM 
CaCl2 or 1.0mM EGTANa2. After brief sonication, the lysates were centrifuged at 15,000g for 30 min 
to remove insoluble components. The supernatants were then applied to his-S100P columns or control 
column with his-binding beads only. After extensive washings with 10mM Tris-HCl, pH 7.4, 150mM 
NaCl, 0.5% (v/v) Tween 20, the bound proteins were eluted  with 300mM  imidazole and then 
subjected to Western blotting using mouse anti-S100P mAb and anti-tubulin antibodies (R&D Systems, 
Abingdon, UK). 
For co-immunoprecipitations, S100P-inducible COS-7 cells were incubated with 1µg/ml doxycycline 
for 16h and lysed in RIPA buffer (Thermo Fisher Scientific, Loughborough, UK) with 0.5 mM CaCl2. 
After sonication and centrifugation as described above, control antibody (rabbit IgG from Sigma), 
anti-tubulin or anti-S100P were added to 3 separate tubes containing 0.7 ml each of cell lysate and 
incubated overnight at 4oC. Then 100 µl Dynabeads ® ProteinG (Thermo Fisher Scientific) were 
added to each tube and the contents incubated for 4h at 4oC. After extensive washings with washing 
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buffer (10mM Tris-HCl, pH7.4, 150mM NaCl, 1% (v/v) Triton X-100, 0.2 mM sodium 
orthovanadate), the bound proteins were eluted with 0.1M glycine pH 2.5 and then subjected to 
Western blotting using the paired antibodies together with a sample of the input and the last wash. 
For SPR binding assays, α,β-tubulin proteins described earlier were immobilised on an aminosaline 
surface of a CMS chip using BS3 for use in Biocore X100. Recombinant S100P (1 µg/ml) produced as 
described previously [10] was used as a ligand in different concentrations at 20, 50, 100, 200, 1000, 
2000 nM for calculation of the equilibrium dissociation constant (Kd) from the 
association/dissociation rate constants and from the extent of binding near equilibrium 
(Supplementary Table S2), as described previously [10, 30]. To detect the effects of tubulin peptides 
on the interaction of tubulin, different concentrations of tagged and untagged peptides were mixed 
with 1µM S100P first and the mixtures were then applied to the tubulin-coated chip. The relative 
changes in kinetics and binding extents with different peptides were calculated using software provided 
by the manufacturer. 
Immunofluorescent staining and confocal microscopy 
S100P-Yellow Fluorescent Protein (YFP) fused to S100P (S100P-YFP) and End Binding Protein 3 
(EB3) fused to Cyan Fluorescent Protein (CFP) (EB3-CFP) expression plasmids, pYFP-S100P and 
pCFP-EB3 were constructed. COS-7 cells were transiently transfected with the two plasmids and 
images were recorded using LSM 5-10 confocal microscope 24h after transfection. CFP: excitation 
436nm, emission = 480nm, YFP: excitation = 500nm, emission = 520nm.  
Immunofluorescent staining was carried out as previously described [31]. COS-7 S10 and MCF-7 
cells were induced for 48h prior to plating at 25,000 cells/well onto either untreated or fibronectin- 
coated (2.5 µg/cm2) glass coverslips in a 24-well plate. After a further 48h, cells were washed once in 
Cytoskeleton Buffer (CB: 150mM NaCl, 5mM MgC12, 5 mM EGTA, 5 mM glucose, 10 mM 2- (N- 
morpholino) ethanesulfonic acid, pH 6.1 prior to fixing with 3.7% (w/v) paraformaldehyde in CB at 
37oC for 20 minutes. Cells were permeabilised with 1% (v/v) Triton X-100 in CB for 2 min and 
blocked with 5% (v/v) goat serum in CB for 60 min before incubation with rabbit anti-EB3 
(Abcam ab157217) and mouse anti-α-tubulin (Sigma T5168) (dilution between 1/400 and 1/500) in 
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1% (v/v) goat serum in CB for 60 min at room temperature. After extensive washing, cells were 
incubated with the appropriate secondary antibodies: anti-rabbit FITC (Dako F0205) and anti-mouse 
Alexa Fluor (Molecular Probes A11004), respectively, for 60 min at room temperature. After 
washing, coverslips were mounted on slides in Vectashield (Vector Labs, UK), before being viewed 
in an Epifluorescence Leica DMI400B microscope equipped with objective lens 63x Leica PH3 
FLUOTAR 25 Oil and excitations at 488nm, emission at 520nm for FITC and excitations 540nm and 
emission 570nm for TRITC. Images were obtained using a Leica DFC360FX digital camera and the 
Leica LAS AF 6000 software. FITC-labelled antibodies to EB3 were used for EB3 staining. 
Quantification of the presence of EB3 clusters at the cell periphery or well-defined MTOC was 
performed by counting the number per cell in about 100 cells selected at random. Results are presented 
as percentages of the cell population containing either an EB3 network at the cell periphery or well-
defined MTOCs. For MTOC quantification, cells and MTOC were graded as shown in Figure 4C’ where 
organization is defined as 1) not visible or poorly structured organization; 2) visible but poorly formed; 
3) visible and defined; and 4) well defined and extensive regions. Cells showing 1-2 grading would be 
considered as poorly defined, whilst cells in 3-4 would be deemed as well structured. Scoring was 
undertaken by observers blinded to identity of samples. 
 
Living colour expression and confocal microscopy 
S100P-Yellow Fluorescent Protein (YFP) fused to S100P (S100P-YFP) and End Binding Protein 3 
(EB3) fused to Cyan Fluorescent Protein (CFP) (EB3-CFP) expression plasmids, pYFP-S100P and 
pCFP-EB3 were constructed. COS-7 cells were transiently transfected with the two plasmids and images 
were recorded using a LSM 5 confocal microscope 24h after transfection. 
 
In vivo tubulin polymerisation assay 
HeLa and S100P-inducible HeLa, COS-7 and S100P-inducible COS-7 cells were routinely cultured 
with or without doxycycline (1 µg/ml) and treated with 33 µM nocodazole for 24h to synchronise the 
cells. Then the nocodazole was washed away (First release) and the synchronised cells were cultured in 
normal medium for 4h to allow them to complete cell division. The nocodazole was then added 
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again for 4h to dissociate all the MTs. After this time, nocodazole was again removed by extensive 
washings (Second release) and tubulin was allowed to polymerise in the interphase of the cell cycle 
for different times [32, 33]. The cells were treated with buffer (10 mM Tris-HCl, 150mM KCl, pH 
7.4, 2% (v/v) Triton X-100) and the Triton-X100-insoluble tubulins (representing the newly formed 
MTs) were solubilised in Sample Buffer and quantified by Western Blotting. To test the effect of 
tubulin-derived peptides, 20 µM T-DIC, T-DLV, T-IMN and tag-peptide alone (Supplementary Table 
S3) in 0.25% (v/v) DMSO as solvent, as well as the solvent control 0.25% (v/v) DMSO were added 
immediately after the second release in Sample Buffer and quantified at the different time points by 
Western blotting. 
 
Trypsin digestion, affinity chromatography, and mass spectrometry 
Fifty µg of α and separately β-tubulins were incubated with 5µg trypsin in 200 μl total volume at 37oC 
overnight in 25 mM ammonium bicarbonate to ensure complete digestion. Resultant peptides were 
diluted in 10 ml Binding Buffer (20 mM Tris-HCl pH8.0, 150mM NaCl, 0.5 mM CaCl2 and 0.5% 
(v/v) Tween 20) and applied to a S100P-conjugated CNBr-Sepharose 4B column in the presence of 
0.5mM CaCl2. After extensive washings, the bound peptides were eluted with 0.1M glycine pH 2.5 
and neutralised immediately. These elutes were analysed using the mass spectrometry service provided 
by the University of Dundee using nanoLC-MS-MS. The raw data was analysed further using Peak 
software 7.0 and all identified peptides were superimposed on the amino acid sequence of α or β-
tubulin. 
 
Peptide synthesis 
Mass spectrometry-identified tubulin peptides were first analysed for their appearance on the surface of 
the 3D structure of α or β tubulin [34] using Z Dock Server, University of Massachusetts, USA. 
Five peptides of 25-30 amino acids long which mapped to the tubulins’ surface were chosen and 
synthesised commercially by Syn Peptides (Shanghai, China) to 98% purity. For in vivo experiments, 
the 10 amino acid TAT-HA2 tag for cell entry [35] was added to selected peptides and new peptides 
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with entry tags were synthesised by the same company (Supplementary Table S3). 
 
NMR spectroscopy 
1H, 15N HSQC spectra were measured at 40oC in 20 mM 2-morpholinoethanesulfonic acid sodium salt 
(MES), 50 mM NaCl2, 0.5 mM CaCl2, 2 mM Tris-carboxyethyl-phosphine (TCEP), pH 6.1 buffer as 
described previously [36]. Samples were prepared from 1.6 mM solution of 15N-labelled S100P and 2- 5 
mM peptide solutions to obtain a 1:1 mixture of 0.1 mM of S100P and 0.1 mM of each peptide. 
Initially, peptide solutions were prepared by weight to produce 5 mM peptide concentrations. Some 
peptides had low solubility and did not fully dissolve, leading to visibly cloudy solutions. In these 
cases buffer was added to reduce the peptide concentration to 2 mM. In the case of 2 peptides, DLV 
and VNA, solutions remained cloudy. These peptides were added to the protein as cloudy suspensions to 
produce 0.1 mM solutions; some precipitations were still detected. To estimate the peptide 
concentrations, equivalent peptide solutions without the protein were prepared. All solutions were 
centrifuged before the NMR measurements. NMR spectra were collected on Bruker Avance III 800 
MHz spectrometer equipped with CryoProbe. Data were processed and analysed in TopSpin 3.5 
(Bruker, Karlsruhe, Germany). 
 
Isothermal titration calorimetry (ITC) 
Measurements were conducted using an ITC-200 instrument (Microcal) as previously described [36]. 
ITC titrations were performed in 20 mM MES pH 6.1, 50 mM NaCl, 1.0 mM TCEP and 5 mM CaCl2 
(for Ca2+-form of S100P) at 25oC. Due to low solubility, peptide solutions at concentrations of 10-400 
µM were place in the cell and titrated with S100P at concentrations of 0.5 – 3 mM, depending on the 
peptide concentration. Data were integrated and fitted to a single site binding equation using Origin 7 
software which was included with the ITC module (Malvern Microcal, Malvern, UK). 
 
Results 
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S100P overexpression increases cell migration but does not reduce cell adhesion in myosin IIA- 
deficient COS-7 cells 
In our previous study, we reported that S100P enhances cell migration by binding to and affecting 
distribution of NMIIA filaments in HeLa and Rama 37 cells [10]. We now sought to determine 
whether S100P overexpression could induce such changes in cells when NMIIA was absent. The 
monkey kidney COS-7 cells have been reported to lack NMIIA [28] and this was confirmed in 
comparison with its presence in human HeLa and rat Rama 37 cells (Figure 1A). We then generated 
three S100P-inducible COS-7 cell lines using doxycycline as the inducing agent, the largest increase 
being in clone S10 (Figure 1B). When 1µg/ml doxycycline was added to COS-7 S10 cells, the 
increase in S100P peaked at 24h and remained constant for at least 72h without effect on the expression 
of tubulin and non-expression of NMIIA (Figure 1C, D). This clone still contained no NMIIA whilst 
the S100P-inducible HeLa cells, HeLa-A19 still expressed NMIIA upon S100P induction (Figure 1E 
C). There was no change in levels of tubulin, no detectable NMIIA nor any S100P when the 
same concentration of doxycycline was added to parental COS-7 cells (Figure 1C, D, F). When 
doxycycline was added for 24h to the three inducible COS-7 cell lines, the relative cell migration 
rates were also significantly increased by 2.5 to 2.9, fold but that for parental COS-7 cells, was 
not (Figure 1G ). In comparison overexpression of S100P in the NMIIA- containing inducible Rama 
37 and HeLa cells caused a 3.2 to 4.8 fold increase in migration rates [10, 37]. In contrast to the 
S100P-inducible cell line HeLa A3 (Student’s t test P ≤ 0.022), there was no significant decrease in 
the rate of adhesion (Supplementary Figure S1) or significant decrease in strength of adhesion 
(Supplementary Figure S2) of S100P-inducible COS-7 S10 cells (P ≥ 0.18) upon addition of 1µg/ml of 
doxycyclin. These results indicate that S100P can enhance cell migration through mechanisms other 
than via NMIIA and cell adhesion in the COS-7 cells. 
 
S100P interacts with tubulin in vitro 
To examine whether S100P interacts with other cytoskeletal proteins, histidine-tagged S100P was 
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immobilised on His-binding resin and used to capture proteins from cell lysates with blank beads as 
control. After extensive washings of the resin α, β-tubulins were detected in eluates, but only when 1 
mM CaCl2 but not EGTA was originally present. Neither S100P nor tubulins were pulled down by 
blank beads control (Figure 2A). When αβ-tubulin was synthesised (Supplementary Table S1), 
immobilised on a chip and its binding affinity to S100P was determined using Surface Plasmon 
Resonance (SPR), the dissociation constant (mean±SE) of the complex measured near equilibrium, Kd 
= 3.1±0.3 x 10-7M determined from multiple-cycle and 2.2±1.6x10-7M from single-cycle analyses 
(Figure 2B, C, Supplementary Table S2). The interaction could occur in both low, physiological 
(0.15M) and high (0.5M) NaCl buffers, equilibrium Kd = 61±3.5x10-7M (Figure 2D, E) and was 
dependent on calcium ions, which started to form the complex above 30µM and saturated the reaction at 
0.2mM (Figure 2F-H). 
 
S100P forms complexes with tubulin in cells 
To demonstrate the existence of S100P-tubulin complexes in S100P-induced COS-7 S10 cells, potential 
complexes were immunoprecipitated with either anti-tubulin or anti-S100P and then probed with the 
reciprocal antibody. We found that the immunoprecipitates produced with anti-S100P also contained 
tubulin on Western blotting (Figure 3A) and vice versa, the immunoprecipitates with anti- tubulin 
contained S100P on Western blotting (Figure 3B). No bands were seen on Western blots of 
immunoprecipitates produced by control IgG serum (Figure 3A, B). A similar result was obtained using 
MCF-7 cells (Figure 3C, D) which expressed native S100P, tubulin and NMIIA (Figure 1C, D, F). 
These results show that S100P- tubulin complexes exist in lysed cells and suggest they may occur 
naturally in intact cells. However, using dually fluorescently-labelled anti-S100P and anti-tubulin 
sera no clear association of S100P with peripheral MTs could be demonstrated except the co-
localization around MT-organizing centres (MTOC) in S100P-induced COS-7 S10 cells (Figure 3E). 
In contrast, in poorly S100P-producing MCF-7 cells, the co-localization could be seen only in a few 
cells and was not as obvious as in S10 (Figure 3F). These results suggest that S100P binds mainly to 
free αβ-tubulin subunits and MT- organizing centres rather than to the peripheral MT filaments. 
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Overexpression of S100P causes changes in MTs organisation 
COS-7 cells were co-transfected with vectors expressing Cyan Fluorescent Protein (CFP) fused to 
End Binding Protein (EB3) (CFP- EB3) to highlight MT termini [17] and simultaneously with 
vectors expressing Yellow Fluorescent Protein (YFP) fused to S100P (YFP-S100P) to delineate 
S100P. We found that the cells expressing high levels of YFP-S100P showed a more dispersed 
distribution of cyan-labelled peripheral MTs than cells which expressed very low levels of S100P 
(Supplementary Figure S3A). YFP cDNA alone-transfected cells showed no effect on MTs 
(Supplementary Figure S 3 B ). These data suggest that high levels of S100P may interfere with the 
distribution or formation of the MTs in living cells. 
To determine whether altering S100P levels would lead to changes in MT-dependent organization, 
S100P-inducible S10 cells were treated with 1µg/ml doxycycline and seeded on coverslips with or 
without fibronectin, fixed and immunofluorescently stained red for tubulin and green for EB3 using 
TRITC and FITC labels, respectively. Some clear disruption could be seen in MTOC and in EB3 
localization at the cell periphery when S100P was expressed (Figure 4 panels A, B) as well as in focused 
peripheral regions (panel B') These changes were further exacerbated when cells were grown on 
fibronectin-coated coverslips where their adhesion and spreading was enhanced (Figure 4B). Whilst 
the overall structure of the MTOC was not compromised, there was much less distinct localization, 
resulting in a reduction by a significant 31% in the percentage of well- defined (Methods) MTOCs per 
cell (Figure 4C). Equally there was a significant reduction of 52% in the percentage of cells 
with bundles of EB3 at the cell periphery when S100P expression had been induced (Figure 4C). 
 
S100P slows down tubulin polymerisation in living cells 
HeLa, HeLa-A19, COS-7 and COS-7 S10 cells were cultured without or with 1µg/ml doxycycline and 
treated with 33µM nocodazole for 24h to synchronise the cells. The nocodazole was then washed 
away and the synchronised cells were cultured in normal medium for 4h to complete cell division. 
The nocodazole was added again to dissociate all the MTs. After this time, nocodazole was removed to 
allow subsequent polymerisation of tubulin in the interphase of the cell cycle (Materials and 
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Methods). The Triton-X100-insoluble tubulins (representing the newly-formed MTs) were then 
detected at successive time points by Western blotting (Figure 5A) and their band intensities plotted 
against time after removal of nocodazole (Figures 5B, C). We found that tubulin polymerisation in 
S100P-induced cells was significantly slower (Student’s t test P < 0.05) by about 30% after 4h than 
that without S100P induction, in both S100P-inducible HeLa-A19 (31% reduced) and COS-7 S10 
cells (32% reduced) (Figures 5D, E). In contrast, when HeLa or COS-7 parental cells were treated 
without or with 1µg/ml doxycycline, the rates of tubulin polymerisation showed no significant 
differences (Figure 5B). These data indicate that S100P overexpression can slow down and change the 
dynamics of tubulin polymerisation in both NMIIA-containing and non-containing cells. 
 
Stabilizing or disrupting MTs suppressed S100P-enhanced cell migration 
It has been reported that stabilizing MTs by taxol significantly reduced cell migration in almost all 
cell types tested [17], whilst dissociation of MTs, by agents such as colchicine or nocodazole, had 
different effects on cell migration in different types of cells. It was reported that complete disruption of 
MTs in CHO and HeLa cells retained normal migration rates, but the resultant movement became 
more random [38] and reduced overall travel distance [39]. In Dictyostelium cells, nocodazole- 
disrupted MTs could significantly increase cell migration and shape changes, but reduced chemotaxis 
[40]. In our studies, we found that taxol significantly reduced cell migration in dose-dependent 
manner (Supplementary Figure S4) and that 20nM reduced migration by 70-75% in rat Rama 37, 
human HeLa, human MCF-7 and monkey COS-7 cell lines (Figure 6A). In contrast, colchicine was 
able to increase dramatically cell migration in a time and dose-dependent manner in MCF-7 cells only 
(Figure 6B, C), but significantly reduced migration in Rama 37, HeLa and COS-7 cells by 30-70% 
(Figure 6D). S100P-enhanced cell migration in Rama 37-T25, HeLa-A3 (both 3-4 folds) or COS-7 
S10 cells (2-3 folds) was suppressed by either taxol (Figure 6E) or colchicine (Figure 6F). These data 
support the argument that dynamic changes of MTs are critical for cell migration and down-regulation of 
tubulin polymerisation could be a major mechanism of S100P-enhanced cell migration. 
 
Identify peptides which specifically interrupt S100P-tubulin interaction 
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To confirm that S100P-tubulin interaction is a major cause of S100P-enhanced cell migration, a 
specific disruptor of this interaction is required. To achieve this goal, we first mapped the binding 
sites of S100P on α, β-tubulin using a gel overlay assay with intact and half molecule tubulin 
fragments. However, S100P interacted with both α and β-tubulin subunits and with all 4 half molecules, 
suggesting the involvement of multiple binding sites (Supplementary Figure S5). Therefore a 
proteomic approach was utilised. Trypsin-digested α or β-tubulin peptides were applied to a S100P-
conjugated Sepharose 4B column. After extensive washings, the bound peptides were eluted and 
characterised using mass spectrometry. The overlapping peptides were identified on the protein 
sequences of α, β-tubulin (Supplementary Figures S6, S7), presumably at potential binding sites. 
Based on published crystal structure of α, β-tubulin heterodimer, the overlapping peptides on its 
surface were selected, including 2 peptides from α-tubulin, one from its N terminus (starting with 
DLV), one from its C terminus (VNA), and 2 peptides from β-tubulin, one from the middle (DIC) 
and one from the C terminal middle (LRF) (Supplementary Figures S6, S7). Another one was chosen 
that was identified by only a single nonoverlapping peptide IMN from β tubulin as a potential control. 
The identities of the selected peptides synthesised are shown in Supplementary Table S3. 
The binding of the synthesised peptides to S100P was determined using NMR and ITC. Addition of 
IMN peptide to S100P had no effect on the NMR spectra of the protein, suggesting lack of interaction 
(Figure 7A). Four other peptides (DIC, DLV LRF and VNA) caused significant chemical shift 
changes in the HSQC spectra of 15N-labelled S100P, with similar signals affected (Figure 7A). This 
result supports the idea that these peptides interact with the same region(s) of S100P. Two of the 
peptides, DIC and VNA, were sufficiently soluble to measure their binding parameters by ITC 
(Figure 7B). Interaction with VNA is relatively weak, with Kd = 62 µM, but significantly stronger for 
DIC (Kd = 9 μM). The unexpectedly high stoichiometry of ~2 (peptide:protein) for VNA may be due to 
some peptide aggregation, which is also suggested by the reduction in intensity of its signals in the 
HSQC spectrum. HSQC signals were also weak for the DLV peptide, solutions of which were visibly 
cloudy even at low concentrations of 0.1 mM, clearly demonstrating peptide aggregation (Figure 7A). 
Thus low solubility of this peptide prevented accurate measurement of its affinity to S100P by ITC. 
However, the similarity of the observed chemical shift changes for DIC and DLV peptides suggested 
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binding constant for DLV was similar to that measured for DIC <10μM. Overall, the in vitro 
experiments validated the interactions of S100P with four different regions of tubulin with low 
micromolar affinities; the affinity for the intact tubulin is expected to be higher through synergy 
between the different binding sites. 
 
Peptides that interrupt S100P-tubulin interaction significantly reduce S100P-enhanced cell 
migration 
To test if 3 of the above peptides could block the interaction of S100P to immobilised αβ-tubulin on a 
SPR chip, 20µM of each peptide (the minimal concentration determined to have maximal inhibitory 
effect), and 1µM S100P were applied to the chip. We found that DIC and DLV peptides significantly 
inhibited the extent of binding of S100P by over 50% (Figure 8A). In contrast, the control IMN 
peptide which did not encompass the major overlapping S100P binding sequences on β-tubulin nor 
bind to S100P in the NMR (Figure 7A) showed no such effect (Figure 8A). Peptides containing N- 
terminal tags of 10 amino acids which enabled them to gain access to cells [35] were also synthesised 
and tested (Supplementary Table S3). The tagged peptides (T-DIC, T-DLV, and T-IMN) inhibited to 
the same extent as their untagged counterparts, since no significant differences between tagged and 
untagged moieties were observed. The Tag of 10 amino acids alone showed no effect in the binding 
assay (Figure 8A). The effect of tagged peptides on the S100P-induced delay in tubulin 
polymerisation in S100P-inducible COS-7 cells was then examined. Twenty µM T-DIC and T-DLV, 
but not control T-IMN completely abolished the 30% inhibition of tubulin polymerisation caused by 
induction of S100P (Figure 8B). These results are consistent with the binding assays. 
Although doxycycline-induction of S100P significantly increased cell migration with all of the tagged 
peptides at 20µM, the extents were very different. The S100P–induced 3.4 or 3.5 fold increase in the 
presence of DMSO or Tag was significantly reduced to 1.4 or 1.5 fold with T-DIC or T-DLV, 
respectively, but not significantly with T-IMN peptide (Figure 8C). Thus in the presence of T-DIC or 
T-DLV, S100P-enhanced cell migration in both NMIIA minus COS-7 S10 and NMIIA plus HeLa- 
A19 cells was significantly reduced by about 60-90% compared to that with DMSO or Tag alone 
18 
controls, but there was no significant reduction with T-IMN peptide (Figure 8D). These data show that 
the effect of S100P on tubulin polymerisation is a major mechanism for S100P-enhanced cell migration 
in NMIIA-containing, as well as in NMIIA-depleted cells. 
Discussion 
Movement away from the primary tumour is the critical first step in metastasis [41, 42]. Previously 
we have demonstrated that both S100A4 and S100P are able to promote metastasis in syngeneic rat 
models for breast cancer and that their overexpression in human primary breast cancers is associated 
with poor patient prognosis [5, 9, 43] due to metastasis, at least to the brain [44, 45] and the liver [46]. 
Moreover, high levels of S100A4 [12] and S100P [10] are able to increase cell migration, in part, by 
binding to the NMIIA component of the actomyosin cytoskeleton, so as to reduce levels of 
actomyosin filaments and focal adhesions to the cellular substrata. In this way the cell adhesive force is 
reduced and the driving force of NMIIB is left relatively unopposed. These changes facilitate the 
detachment of cancer cells and promote their spread through the extracellular matrix [10]. In the 
current study, we report that overexpression of S100P in a cell line, COS-7 without any detectable 
NMIIA, can still enhance cell migration, but without a corresponding decrease in cell adhesion 
(Supplementary Figures S1, S2). This work is the first to establish a direct cause and effect relationship 
between S100P and cell migration that is independent of the actomyosin cytoskeleton and adhesive 
properties of cells. Furthermore, we show that this S100P-induced increase in cell migration occurs 
instead through the interaction of S100P with αβ-tubulin and its consequent reduction in tubulin 
polymerisation in these NMIIA-depleted COS-7 cells. That S100P and tubulin interact in vivo has been 
demonstrated by pulldown experiments from lysed cell extracts using antibodies to either component 
separately (Figure 3A, B) and by use of externally-added fluorescently-labelled antibodies to 
permeabilised cells (Figure 3E, F). To eliminate the possibility that complex formation occurs after cell 
lysis or indeed after permeablisation, colocalisation of endogenously fluorescently-labelled S100P and 
EB3-capped tubulin was also shown to occur in intact living cells (Supplementary Figure S3).  
Cell migration is a complicated biological process involving many disparate cellular machines and 
regulatory systems [47]. The cytoskeleton is essential for cell migration and is composed of 3 major 
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types of fibres, intermediate filaments, actomyosin filaments and MTs [48]. The intermediate 
filaments mainly provide mechanical strength to cells, whilst actomyosin filaments directly provide 
forces for cell migration [49]. The roles of MTs in cell migration are more complex. On the one hand, 
MTs are a major support to cell polarity and their assembly can provide force for directional 
movement [50]. On the other hand, MTs make a cell’s shape more rigid and thereby reduce their 
motile efficiency. From our experiments, we find that S100P can interact with nonpolymerised α, β- 
tubulin in test tubes using three independent assays: binding of cell lysates to His-tagged S100P beads 
(Figure 2A), SPR binding to immobilised tubulin (Figures 2B-H) and gel overlay assay 
(Supplementary Figure S5). The fact that such complexes can occur in intact cells is demonstrated 
using immunoprecipitation of cell lysates (Figure 3A, B). All 3 assays exhibit the same requirement for 
Ca2+ ions before interaction is observed. Once the Ca2+ concentration drops to 30µM no binding signal 
of S100P to tubulin is detectable in the SPR assay which saturates at 200µM (Figures 2F-H). These 
concentrations are high, average Ca2+ levels are 100nM or so in cells, although it is not unusual to see 
intracellular concentrations of 1µM or more following extracellular signalling activation or intracellular 
messenger releases (51). These concentrations may rise still higher in distinct microdomains within the 
cytoplasm caused by opening of Ca2+ channels within the plasma membrane or endoplasmic reticulum 
(52, 53). These concentrations may still represent an apparent discrepancy in that many S100 proteins 
bind Ca2+ in the 10-50µM range in vitro, well above the level observed in vivo [54]. However, when 
binding of Ca2+ to preformed S100A4/NMIIA fragments was studied using ITC, its Kd value was 
reduced by serveral orders of magnitude [55]. In addition to S100A4, S100B and several other S100 
proteins bind Ca2+ ions relatively weakly in the absence of protein targets (Kd > 1µM). In contrast when 
they bind to their target proteins, Ca2+ binding can increase by as much as 200 to 400 fold [56]. 
Moreover, to observe binding of S100P to interferon β (57) or V domain of RAGE (58) using either SPR 
or ITC/tryptophan fluorescence, respectively, Ca2+ concentrations of 1 to 4 mM were employed. Thus it 
may be that the local intracellular concentrations of Ca2+ peak at higher values than those observed on 
average in the cytoplasm of activated cells and/or the requirement for Ca2+ ions is greatly reduced by the 
configuration of S100P-tubulin perhaps complexed with additional proteins/ions in vivo compared to that 
in vitro.  
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In our hands, the Kd of the interaction between S100P and tubulin from SPR analysis is 2-3x10-7M, as 
calculated from estimates at or near equilibrium or 1-2 x 10-7 from a ratio of forward and backward 
rate constants [59]. Moreover, binding of S100P to tubulin is shown to occur throughout both α, β 
forms via multiple binding sites (Supplementary Figures S5-S7). Thus S100P interacts mainly with 
unpolymerised αβ-tubulin, presumably to prevent its assembly into MTs (Figure 5E) and thereby may 
change MTs dynamics. These results are also consistent with those found previously for the binding of 
S100A1 or S100B to tubulin and their reduction in assembly into MTs in brain cells [24, 25, 60, 61]. 
Using either living colours (Supplementary Figure S3) or antibody labelling (Figures 3 and 4) to 
monitor MTs, we find that in both cases overexpression of S100P causes the MT filaments to be less 
distinctive. In particular, the EB3-capped MTs at the cellular peripheries are significantly reduced by 
about 52% and there is a 31% loss in MTOCs per cell (Figure 4); results which are consistent with the 
near steady-state reduction of 33% in biochemical assembly of MTs (Figure 5E). Localisation of 
S100P is mainly nuclear and perinuclear (Figure 3E). Distinctive co-localisation of S100P with α, β 
tubulins mainly appears in MTOCs (Figure 3E) in COS-7 cells. All these results suggest that 
overexpression of S100P can affect the dynamics of MTs within COS-7 cells. This conclusion is not 
due to lack of NMIIA in COS-7 cells, since a virtually identical reduction in rate of polymerisation of 
tubulin is observed in NMIIA-containing, S100P-inducible HeLa cells (Figures 5D, E). 
The chemicals taxol and colchicine have much stronger effects on tubulin polymerisation than those of 
S100P (Figure 6). Taxol, a stabiliser of MTs [62], significantly reduces cell migration in all cell lines 
tested (Rama 37, HeLa, MCF-7 and COS-7), even at a very low concentration of 20nM (Figure 6A). 
This concentration completely prevents the S100P-induced stimulation of migration in the 
NMIIA-depleted (COS-7), as well as in the NMIIA-containing (Rama 37, HeLa, MCF-7) cells 
(Figure 6A). In contrast, colchicine, an MT disrupter [19 - 21], enhances cell migration in a time 
(Figure 6B) and concentration (1-10µM) dependent manner in MCF-7 cells (Figure 6C), although 
longer times of incubation (>24h) or higher concentrations (>10µM) abolishes this effect (Figures 6B, 
C), However the same concentration of 5μM which stimulates cell migration in MCF-7 cells inhibits 
migration of Rama 37, HeLa and COS-7 cells (Figure 6D). These observations strongly suggest that 
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excessive MT formation or complete disruption definitely inhibits cell migration and overrides any 
stimulation produced by induction of S100P in our experiments (Figure 6E, F). In contrast results for 
subsaturating concentrations of colchicine, at least for MCF-7 cells (Figure 6B, C), suggest that in the 
case of the NMIIA-depleted cells, S100P and colchicine may be stimulating the same pathway for cell 
migration. However, S100P-enhanced cell migration appears to be caused not simply by blocking 
MTs assembly, but more likely by changing MTs dynamics. Moreover, there are other examples of 
proteins such as CAP-Gly domain-containing proteins P120-catenin [63] and certain pathways such as 
PI3 kinase-Akt [64] that regulate the dynamics of MT and can affect cell migration. For example 
overexpression of P120- catenin can stabilise the MTs and reduce cell migration, whilst knocking-
down P120-catenin can destabilise the MTs and increase cell migration [63].  
Despite the many reports which have shown that disruption of MTs can impair cell migration, 
particularly directional migration, cells can still retain the ability of persistent motility without MTs 
[65], presumably using other components of the cell’s cytoskeleton [47]. Well-established MTs may 
increase the rigidity of cells as well as their polarity and play a constraining role to limit a cell’s 
ability of moving and changing direction [66]. Disrupting MTs using nocodazole can dramatically 
enhance the non-directional (random) movements of cells [67]. However, unlike the scratch wound- 
healing assay which relies on directional migration of cells, the transwell migration assay used here is a 
reliable method to measure the cell’s non-directional migration in space, although a nutrient gradient of 2 
to 10% (v/v) FCS is applied across the membrane separating the chambers [68-69]. 
To prove that the effect of S100P on tubulin is the major mechanism of S100P-enhanced cell 
migration in NMIIA-depleted COS-7 cells, we have used the two strongest S100P-binding peptides 
tested in ITC, the 30mer starting with DLV from α-tubulin and the 26mer starting with DIC from β- 
tubulin, as well as a very weak or nonbinder as a control, the 30mer starting with IMN from β-tubulin 
(Supplementary Table S3; Figure 7). The location of these peptides in the αβ dimer crystal structure 
suggest that DLV and DIC are on surfaces which are involved in tubulin polymerization whilst IMN is 
partially burried (Figure 9) probably weakening IMN’s ability to bind to S100P. They were all tagged 
with a S100P-binding-inert (Figure 8A) 10 amino acid peptide (T) to enable them to enter cells [35]. 
Since the two peptides, T-DIC and T-DLV which cause a significant 50% reduction in extent of 
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binding of S100P to tubulin (Figure 8A), virtually abolish both the S100P-induced decrease in 
tubulin polymerisation (Figure 8B) and the S100P-induced increase in cell migration (Figures 8C, D), 
the binding of S100P to α, β-tubulin would appear to be an obligatory step in the overall process. 
Moreover, since there is no change in either tubulin polymerisation or cell migration produced by 
these two tagged peptides in uninduced COS-7 cells (Figures 8B, C), the two binding sites on intact α, 
β tubulin represented by the DIC and DLV- containing peptides are probably uniquely recognised by 
S100P and perhaps similar S100 proteins. 
In the case of NMIIA-containing HeLa cells, the two inhibitory peptides DIC and DLV still 
significantly blocked the S100P-induced increase in cell migration, but only by 49% and 54%, 
respectively. This result suggests that, although part of the S100P-induced stimulation of cell migration 
in HeLa cells is caused by S100P binding to tubulin, the remainder is caused by another mechanism, 
in this case probably S100P binding to NMIIA [10]. These results are consistent with the fact that 
the tagged NMIIA peptide which inhibits the binding of S100P to NMIIA, reduces S100P’s 
stimulation of migration by about 50% [10], leaving about 50% of stimulation unassigned. It is 
suggested that this unassigned stimulation is due to S100P interacting with tubulin and that S100P can 
bind to both NMIIA [36] and α, β-tubulins in cells containing NMIIA to propagate two independent 
pathways that stimulate cell migration. Since coordination of MTs and actomyosin filaments is 
important in cell migration [48, 70], S100 proteins like S100P or S100A4 may undertake this role 
in promoting cell migration, particularly in the neoplastic cell. Therefore, one possible reason for 
the widespread occurrence of certain S100 proteins in metastatic cancers [71-73] may be due to the 
promiscuous nature of their interactions with proteins linked to stimulating cell migration and invasion, 
the first major step in the metastatic process. 
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Figure Legends 
 
Figure 1. S100P enhances cell migration in COS-7 cells with undetectable nonmuscle 
myosin IIA. (A) Western blot with anti-nonmuscle myosin IIA and anti-β-actin. There was 
no band at 226 kDa corresponding to nonmuscle myosin IIA (IIA) in monkey COS-7 cells 
compared to that seen in human HeLa and rat Rama 37 cells. The gels have been overexposed 
to detect even the smallest trace of NMIIA. (B) Three clones of S100P-inducible COS-7 cells 
(S7, S10, S23) were exposed to 0 (c) or 1µg/ml (d) doxycycline for 24h. Western blot of 
equal amounts of loaded proteins shows relative S100P levels. In addition to monomeric 
S100P at an apparent mol wt of 10kDa (arrow), multimeric forms can also be seen in these 
overexposed gels. (C) Effects of doxycycline on the abundance of tubulin. Upper panel: 
Typical Western blot for β-tubulin and actin in cell lines treated without (-) or with (+) 1µg/ml 
doxycycline for 24hr using both rabbit anti-β-tubulin (Abcam) and rabbit anti-actin (Abcam) 
(Methods). Lower panel: the relative percentage (%) ratios of band densitites of tubulin/actin in 
dot plots with bars representing means showed no significant difference between paired 
doxycycline-treated cells and control cells (Students t-test, P>0.05). (D) NMIIA abundance in 
cell lines. Western blot was performed simultaneously using rabbit anti-nonmuscle myosin IIA 
(NMIIA) (Abcam), rabbit anti-β-tubulin (Abcam) and rabbit anti-actin (Abcam) to detect protein 
levels of NMIIA, β-tubulin and actin in cell lines as indicated from cultures treated without (-) or 
with (+) 1µg/ml doxycycline for 24hr (Methods). No NMIIA was detected in the COS-7 cell 
lines under either condition. MCF-7 produced NMIIA, but at a lower level than MDA-MB-231 
and HeLa cell lines. Extra, perhaps nonspecific protein bands were seen in HeLa cells with this 
anti-NMIIA antibody. (E) Western blot for NMIIA (IIA) and actin in S100P-inducible HeLa-
A19 and COS-7 S7 S10 cells treated for 24h with 1µg/ml doxycycline. There was no band 
corresponding to NMIIA in treated or untreated COS-7 cells S10 cells. (F) S100P abundance in 
cell lines. Western blot was performed using anti-S100P antibody (R&D system) 1/1000 on cell 
lysates from cultures of Huma 62 (Human Breast benign cell line for negative control), MCF-7, 
COS-7 parental cells without (-) or with (+) 1µg/ml doxycycline for 24hr and COS-7-S10 
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(S100P-inducible) cells with (+) doxycycline under the same conditions (Methods). S100P 
protein was detected only in MCF-7 and COS-7-S10 treated with doxycycline.  (G) Cell 
migration assay of parental COS-7 (set at 100%) and COS-7 S7, S10 and S23 cells in the absence 
(Non-induced) or presence (Induced) of 1µg/ml doxycycline for 24h in dot plots with bars 
representing means. *Student’s t test, p<0.01 when compared to non-induced control.  
Figure 2. S100P binds to αβ-tubulins in vitro. (A) Pulldown assay. His-S100P was loaded on 
His- binding beads. COS-7 cell lysates were applied to control beads (His-binding beads only) (a 
and b) or His-S100P beads (c and d) in the presence of 1mM CaCl2 (a and c) or EGTA 
(b and d). After extensive washings, bound proteins were eluted with 300mM imidazole from 
each bead and any His- S100P or α, β-tubulins were detected by Western blotting using anti-
S100P (Upper panel) or anti- tubulin (Lower panel) antibodies. B-F, Surface Plasmon 
Resonance (SPR) binding assays using αβ- tubulin immobilised on a chip and different 
concentrations of S100P in solution. (B) Typical binding curves of response units (RU) in arc 
seconds against time in physiological buffer of 0.15M NaCl with 200µM CaCl2 and multiple 
cycles of different concentrations of S100P. (C) A typical corresponding graph of response 
(RU) plotted against semilog of different concentrations of S100P for calculation of dissociation 
constant (Kd) at or near equilibrium for one experiment. (D) Typical binding curves of 
response (RU) in arc seconds in high salt buffer (0.5M NaCl) with 200µM CaCl2 and multiple 
cycles of different concentrations of S100P. (E) Corresponding graph of response (RU) 
plotted against semilog of different concentrations of S100P for calculation of Kd at or near 
equilibrium for one experiment. (F) Typical binding curves in physiological buffer of 0.15 
M NaCl for fixed concentration of 2 µM S100P and multiple cycles of different concentrations 
of CaCl2. The values of the means±SE from 3 experiments are quoted in Supplementary Table 
S2 (G and H). Typical binding curves of S100P (2µM) to immobilized tubulin showing 
response units (RU) in arc seconds plotted against time for lower concentrations of CaCl2 in 
physiological buffer containing 0.15M NaCl. The different concentrations of CaCl2 used were 0, 
0.01, 0.03, 0.1, 0.3, 1.0, 3, 10, 30 and 100µM. (G) shows that near maximal binding appeared 
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when calcium ions reached 100µM. (H) shows that no significant binding was detected when 
calcium ions were lower than 30µM. 
Figure 3. S100P binds to αβ-tubulins in vivo. ( A and B), Co-immunoprecipitations in 
S100P transfected cells. (A) S100P- induced COS-7 S10 cell lysates were divided in three 
parts, one part was Western blotted directly for tubulin (Input), remaining parts were 
combined and immunoprecipitated with anti-S100P serum bound to beads. The eluate from 
the control antibody-bound beads (Control antibody), eluate from anti-S100P-bound beads 
(Anti-S100P) and last wash from the anti-S100P-bound beads (Last wash) were probed with 
anti-tubulin serum on Western blots. ( B ) Similar lysates were divided into three parts, one 
part was Western blotted (Input) for S100P and remaining parts were combined and 
immunoprecipitated with anti-tubulin-bound to beads. The elute from control antibody-bound 
beads (control antibody), from anti-tubulin-bound beads (Anti-tubulin) and last wash (Last 
wash) were probed with anti-S100P serum. (C and D) Co-immunoprecipitations of native 
S100P. Co-immunoprecipitations of S100 and tubulin in MCF-7 cell lysates using (C) ant-S100P 
or (D) anti-β-tubulin as well as control antibody were undertaken. The eluates and last washes 
from the antibody-bound beads were subject to Western blotting using (C) anti-β-tubulin or (D) 
anti-S100P as described above (Methods). Control antibody in (C) showed a weak band, which 
may be due to cross-reacting contaminant. However, this does not affect the conclusion that 
complex formation can occur between endogenous S100P and tubulin. (E and F) Typical 
confocal images of (E) COS-7 S10 cells induced for 24h with 1µg/ml doxycycline or (F) 
MCF-7 cells and immunofluorescently stained with TRITC- labelled anti-S100P (red) and 
FITC-labelled anti-tubulin antibodies (green). Yellow arrows indicate the nuclei and white 
arrows indicate the mitotic organising centres (MTOC). Bars = 20 µm. 
Figure 4. S100P expression leads to MTOC disruption and changes in EB3 localization 
at the cell periphery in COS-7 cells. COS-7 S10 cells were induced for 48h with 1µg/ml 
doxycycline (Induced) or left untouched (non-induced) prior to seeding on (A) glass or (B) 
fibronectin (FN)-coated glass coverslips. After a further 48h incubation in the same but 
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fresh media, cells were dually immunofluorescently-stained with TRITC-labelled antibodies to 
tubulin and FITC-labelled antibodies to End Binding Protein 3 (EB3). Nuclei were 
counterstained blue with DAPI. Typical images are presented. White arrows indicate the 
well-defined mitotic organising centres (dMTOC), red arrows indicate the clear EB3 bundles 
at cellular periphery. Yellow arrows indicate the MTOC that are not well-defined by EB3 
staining. Bars=50µm. Images in B’ correspond to the enlarged regions of the highlighted 
cells. (C) The number of well-defined mitotic organising centres (dMTOC) or EB3 bundles at 
the cellular periphery were counted and the percentage of cells containing such structures are 
presented as dot plots with bars representing means. *Student’s t test, P<0.001 when S100P 
expressing cells (S100P) were compared with controls. Images in C’ correspond to the 
quantification of how formed MTOC were quantified with cells showing 1) not visible or poorly 
structured organization; 2) visible but poorly formed; 3) visable and defined; and well defined 
and extensive regions (Methods). Both MTOC organization and EB3 localization at the cell 
periphery were disrupted when S100P is expressed. 
Figure 5. S100P slows down tubulin polymerisation after nocodazole treatment. HeLa, 
S100P- inducible HeLa (HeLa-A19) cells, COS-7 and S100P-inducible COS-7 (COS-7 
S10) cells were synchronised by nocodazole for 24h and released for 4h to allow completion 
of cell division, then treated with nocodazole for 4h to dissociate MTs, all without (-) or with 
(+) 1µg/ml doxycycline (+ Doxy). After the second release, the Triton-X100-insoluble 
tubulins were detected at subsequent times using Western blotting. Typical Western blots for 
(A) HeLa and HeLa-A3 and corresponding quantifications for (B) HeLa and (C) HeLa-A19 
cells are presented. (D and E) Comparisons of the relative numbers of MTs at different times 
after release from nocodazole in the absence (Doxy-, set at 100%) or presence of 1µg/ml 
doxycycline (Doxy+) in (D) HeLa-A19 or E, COS-7 S10 cells are presented as dot plots with 
bars representing means.*Student’s t test, P<0.05 when compared to that at the same time but 
without doxycycline. 
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Figure 6. Effect of MT regulators on S100P-enhanced cell migration. (A) Dot plots of 
relative cell migration of different cell types in the absence (Taxol-, set at 100%) or presence 
of 20nM taxol (Taxol+) over 24h are presented with bars representing means. *Student’s t test, 
P<0.01. (B) Time course of number of migrated MCF-7 cells relative to their input number 
expressed as a percentage in the absence (Control) or presence of 5µM colchicine. The drop in 
migrated cells after 48h is probably due to cell death. (C) Dose response of percentage 
changes in cell migration of MCF-7 cells to exposure to different concentrations of 
colchicine for 24 h. (D) Dot plots with bars representing means of relative cell migration over 
24h of different cell types are presented in the absence (Colchicine-, set at 100%) or presence 
of 5µM colchicine (Colchicine+). *Student’s t test, P<0.01. (E and F) Dot  plots  of relative 
cell migration of S100P-inducible cell lines: clone of Rama 37 T25 (T25), HeLa A3 (A3), 
COS-7 S10 (S10) in the presence of (E) 20nM taxol or (F) 5µM colchicine without (Doxy-, 
set at 100%) or with 1µg/ml doxycycline (Doxy+) over 24h are presented with bars 
representing means. Student’s t test, P>0.05 for all paired comparisons. 
Figure 7. α, β-tubulin peptides bind to S100P. (A) Superposition of HSQC spectra of 0.1mM 
15N- labelled S100P in the free solution (red) and in the presence of equimolar 
concentration of α, β- tubulins (Tubulins) or different tubulin peptides (blue), as indicated 
on each panel. Examples of similar changes in HSQC spectra of peptides upon binding are 
encircled. (B) Thermodynamic parameters of the 3 best binding peptides from NMR data 
measured by isothermal titration calorimetry (ITC) calculated from the best-fit curves: 
dissociation constant (Kd), molar ratio (N), enthalpy change (ΔH) and entropy change (ΔS) per 
mole. 
Figure 8. Effects of selected tubulin peptides on S100P binding, tubulin polymerisation 
and cell migration. (A) Surface Plasmon Resonance (SPR) assay to measure the effects of 
20µM selected peptides on the extent of binding of 1µM S100P to a αβ-tubulin-coated chip. 
The peptides included DIC, DLV, and IMN without or with the Tag for cell entry, as well 
as the 10 amino acid Tag alone. *ANOVA test, P<0.05 when compared to S100P alone set at 
34  
100%. (B) Effects of 20µM tagged peptides (T-DIC, T-DLV, and T-IMN with Tag alone and 
solvent DMSO as controls) on S100P reduction in tubulin polymerisation after 4h in 
1µg/ml doxycycline-induced COS-7 S10 cells. *Student’s t-test; P<0.05 when compare 
Doxy+ (with S100P induction) to Doxy- (without S100P induction, set at 100%). (C) Effects 
of 20µM tagged peptides on S100P-enhanced cell migration after 8h in 1µg/ml doxycycline-
induced COS-7 S10 cells. *Student’s t test P<0.05 when compare Doxy+ (with S100P 
induction) to Doxy- (without S100P induction, set at 100%), T-DIC; P=0.046. # P<0.01 when 
compared to Doxy+ DMSO and Tag controls, indicating the inhibition of S100P-enhanced 
migration by peptides. (D) Comparison of S100P-enhanced relative cell migration after 8h for 
NMIIA- COS-7 S10 cells or NMIIA+ HeLa-A19 cells in the absence or presence of 20µM 
tagged peptide (without S100P induction, set at 100%). #ANOVA test, P<0.01 when compared 
to S100P-enhanced migration with addition of DMSO, Tag alone or T-IMN, the negative 
control. *Student t test P<0.05 when compared to COS-7 S10 cells. In A, B, C, D dot plots of 
percentages are shown with bars representing means. 
Figure 9. Position of the peptides in the structure of αβ-tubulin dimer. The locations of 
peptides DLV, DIC and IMN in αβ-tubulin dimer crystal structure from PDB database (Ref 
1JFF) (green: α-tubulin, cyan: β-tubulin) are shown in different colours. DLV and DIC are on the 
surfaces which are involved in tubulin polymerization. IMN is partially burried. 


















1 
 
 
Direct interaction of metastasis-inducing S100P protein with tubulin causes enhanced cell 
migration without changes in cell adhesion 
M. Du, G. Wang, I. Barsukov, S. Gross, R. Smith and P.S. Rudland 
Supplementary Material 
 
 
 
Supplementary Tables 
 
Supplementary Table S1: Primers used for recombinant protein production 
 
Peptides 5’ primer 3’ primer 
 
α tubulin  CGTATCCACTCATATGCGTGAGTG
CATCTCCATCC 
 
CTACTGGATCCTTAGTATTCCTCTC
CTTCTTCCTC 
α tubulin N-
terminus(αN) 
 
CGTATCCACTCATATGCGTGAGTG
CATCTCCATCC 
CTACTGGATCCTTAATATGTGGCCA
GAGGGAAGTG 
α tubulin C-
terminus(αC) 
 
CGTATCCACTCATATGCCTGCATC
TCTGCTGAGAAAG 
CTACTGGATCCTTAGTATTCCTCTC
CTTCTTCCTC 
β tubulin N-
terminus(βN) 
 
GATGCGTAGCATATGCGTGAAATT
GTCCATATTCAG 
TAGATGGATCCTTAGATGTCATAG
AGGGCCTCATTG 
β tubulin C-
terminus(βC) 
 
GATGCGTAGCATATGTTCCGTACC
CTGAAGCTGACG 
GATGCGTAGCATATGCGTGAAATT
GTCCATATTCAG 
 
  
2 
 
Supplementary Table S2: Summary of SPR binding of S100P to αβ-tubulin 
 
Buffer (procedure)  Equilibrium dissociation constant Kd x107  
Kinetica Equilibriumb 
150mM NaCl, 0.5mM 
CaCl2 (single cycle) 
 
1.2±0.12 
 
 
 
2.2±1.6 
150mM NaCl, 0.5mM CaCl2 
(multiple cycles) 
 
2.1±0.9 3.1±0.3 
 
300M NaCl, 0.5mM CaCl2 
(multiple cycles) 
 
8.9±0.9 11±1.6 
500M NaCl, 0.5mM CaCl2 
(multiple cycles) 
 
83±7 61±3.5 
150M NaCl, EDTA 5mM 
(multiple cycles) 
 
1Lc 1Lc 
 
a Mean equilibrium dissociation constant Kd calculated from the association and dissociation rate 
constants using SPR (Materials and Methods) ± SE from 3 separate experiments. 
 
b Mean Kd calculated from extent of binding at or near equilibrium ±SE from 3 separate experiments. 
 
c 1L incalculably large.  
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Supplementary Table S3: Identity of tubulin-related peptides synthesised 
 
 
 
a Half molecule fragments containing N or C terminal of α or β-tubulin 
 
b Region defined by amino acid residues in α or β-tubulin 
 
c Arbitrary peptide identifying number (Supplementary Figs S11, S12) 
 
d Substitute one AA in peptide from original sequence 
 
e Defined in ref 10
Fragmenta, Region 
of tubulinb. 
Peptide 
identifierc 
Sequence synthesized Size (AA) 
α-N,  116-145 1 DLVLDRIRKLADQCTGLQGFLVFH-
SFGGGT 
 
30 
α-C, 328-357d 2 VNAAIATIKTKRTIQFVDWCPTGFK-
VGINY 
 
30 
β-N, 163-190d 3 IMNTFSVVPSPKVSDTVVEPYNATL-SVH 
 
30 
β-N, 209-234 4 DICFRTLKLTTPTYGDLNHLVSATMS 
 
26 
β-C, 240-264  5 LRFPGQLNADLRKLAVNMVPFPRLH  
 
25 
Non muscle myosin IIA 
peptidee 
 ASTRLKQLKRQLEEAEEEAQRANAS-
RKLQRELEDATETADAMNREVSSL-
KNKLRRGDLPFVVPRRMARKG 
 
71 
Tag  RRRQRRKKRG 
 
10 
Tagged DLV 1 RRRQRRKKRGDLVLDRIRKLADQCT-
GLQGFLVFHSFGGGT 
 
40 
Tagged DIC 4 RRRQRRKKRGDICFRTLKLTTPTYGD-
LNHLVSATMS 
 
36 
Tagged IMN 3 RRRQRRKKRGIMNTFSVVPSPKVSDT-
VVEPYNATLSVH 
40 
4 
 
 
 
 
 
Supplementary Figure S1. Rate of adhesion assay  
Percent cells remaining that have adhered to tissue culture wells at different times after initial seeding are 
shown (Materials and Methods). (A) Control uninduced HeLa A3 cells and doxycycline-induced HeLa 
A3 cells. Differences at 30 min Student’s t = 3.6, P = 0.022; 1 hour t= 4.3, P= 0.013; 2 hour t = 9.3, P = 
0.0007, n =3. (B) Control uninduced COS-7 S10 cells and doxycycline-induced COS-7 S10 cells. 
Differences at 30 min t = 0.4, P = 0.69; 1 hour t = 1.6, P = 0.19; 2 hour t = 1.6, P = 0.18, n = 3. Means +/- 
SD of each experiment (n=3) are shown. Asterisk (*) indicates significantly different between uninduced 
control and S100P-induced cells (Student’s t-test, P < 0.05).  
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Supplementary Figure S2. Strength of adhesion assay  
Cells (80% confluent) were predigested with dilute 0.0125% (w/v) trypsin in versene for 5 min to remove 
weakly bound cells. The remaining bound cells were removed and counted using standard procedures. 
Values are expressed as a percentage of the original number of cells seeded. When control uninduced 
HeLa A3 cells and doxycycline-induced HeLa A3 cells were compared, there was a significant 1.58 fold 
decrease in the strength of adhesion upon induction of S100P (Student’s t = 6.7, P = 0.022, n = 3). When 
uninduced COS-7 S10 cells and doxycyclin-induced COS-7 S10 cells were compared there was no 
significant change in the strength of adhesion upon induction of S100P (t = 0.6, P = 0.95, n = 3). Asterisk 
(*) indicates significantly different between uninduced control and S100P-induced cells (Student’s t-test P 
< 0.05). 
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Supplementary Figure S3. Effect of S100P on the distribution of MTs in COS-7 cells. Upper panels 
(A): COS-7 cells were transiently co-transfected with expression vectors for Cyan Fluorescent Protein 
coupled to End Binding Protein 3 (CFP-EB3) and for Yellow Fluorescent Protein coupled to S100P 
(YFP-S100P) and photographed after 24h. Lower panels (B): COS-7 cells were transiently co-
transfected with expression vectors for CFP-EB3 (Cyan) and for YFP alone (Yellow) as a control and 
photographed for the same time. Typical images are presented. Bars=50µm. 
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Supplementary Figure S4. Effect of different concentrations of taxol on cell migration of COS-7 
cells.  
The percentage of input cells which migrated after 24h is shown for different concentrations of taxol in 
nM. 
 
  
0
1
2
3
4
5
6
7
0 50 100 150 200 250 300 350 400 450
Taxol (nM)
Ce
ll m
igr
ati
on
 (%
) 
8 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S5. Gel overlay assay  
Equal molar concentrations of control lysozyme (Lys) as negative control, nonmuscle myosin peptide 
(IIA, as positive control; Supplementary Table S3; ref 10), αβ-tubulin dimer (αβ), His-α-tubulin (α), β-
tubulin (β), α-tubulin N/C-terminus half molecules (αN, αC); β-tubulin N/C terminus half molecules (βN, 
βC) were subjected to SDS-PAGE on 10% (w/v) polyacrylamide gels, transferred onto PVDF membrane 
and incubated with 3 µg/ml S100P protein. The bound S100P was probed with anti-S100P serum and 
visualized with ECL (Methods). 
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Supplementary Figure S6. Identification of α-tubulin peptides that bind to S100P 
Tryptic digests of α-tubulin were applied to a S100P-conjugated Sepharose 4B column. After extensive 
washings, any bound peptides were eluted with 0.1M Glycine pH 2.5 and analyzed in a mass 
spectrometer (Dundee University Mass Spectrometry Service). The different peptides in blue were 
aligned qualitatively on the known human α-tubulin sequence using PEAK 7 software. Modifications 
introduced prior to or during the mass spectrometric analysis are also shown. The peptides labelled 1 and 
2, selected for synthesis in Supplementary Table S3, are also shown superimposed on the amino acid 
sequence for α-tubulin. 
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Supplementary Figure S7. Identification of β-tubulin peptides that bind to S100P 
Similar to Figure S6, the alignments of the mass spectrometry-identified sequences of isolated β-tubulin 
tryptic peptides are shown in blue. These sequences were obtained from mass spectrometric analysis of 
tryptic digests of β-tubulin bound to S100P-conjugated Sepharose 4B beads using PEAK 7 software. The 
peptides labelled 3-5 selected for synthesis in Supplementary Table S3 are shown superimposed on the 
amino acid sequence for β-tubulin. 
